Results for "Understanding Pharmaceutical Distribution"
HDA Statement on FDA Approval of Florida’s Prescription Drug Importation Plan
Healthcare Distribution Alliance (HDA) President and CEO Chip Davis released a statement regarding the Food and Drug Administration’s (FDA) decision to authorize the Florida Agency for Health Care Administration’s drug importation program under section 804 of the Federal Food, Drug, and Cosmetic Act.
Five Things to Know: Pharmaceutical Distributors and Vaccine Distribution
The successful development of COVID-19 vaccines will mark a groundbreaking step in our fight against the pandemic. However, the massive demand for approved vaccines and therapies as they come to market will require extensive coordination across the pharmaceutical supply chain and with the public sector.
HDA Statement on U.S. District Court Ruling in Huntington and Cabell County, West Virginia
The Healthcare Distribution Alliance released the following statement on the ruling by the U.S. District Court for the Southern District of West Virginia regarding the litigation in Huntington and Cabell County.
Advocacy in Action: KeySource Capitalizes on Congressional Recess To Meet with Rep. Landsman
On August 25, HDA member KeySource hosted Congressman Greg Landsman (D-Ohio) and his staff at the company’s distribution center in Cincinnati, Ohio. KeySource CEO and HDA Board Member Albert Paonessa, III, and his team — including CFO Ryan Sevek, Fulfillment Vice President Thom Coleman, Sr. Vice President of Legal Affairs Robert Brown and Director of Fulfillment Stacy Ives — described KeySource’s role in the pharmaceutical supply chain as a national distributor of generic products to retail pharmacies, hospitals, clinics and other sites of care.